|
Completed
|
NCT00970203 -
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
|
Phase 2 |
|
Completed
|
NCT01400555 -
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
|
Phase 1 |
|
Terminated
|
NCT03685591 -
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
|
Phase 1 |
|
Completed
|
NCT00643617 -
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
|
N/A |
|
Recruiting
|
NCT01581749 -
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
|
Phase 4 |
|
Completed
|
NCT01424930 -
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 2 |
|
Completed
|
NCT01228760 -
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
|
Phase 1 |
|
Completed
|
NCT00544440 -
An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma
|
Phase 2 |
|
Terminated
|
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
|
|
Suspended
|
NCT02759744 -
Fusion Guided Focal Laser Ablation of Prostate Cancer
|
N/A |
|
Completed
|
NCT00474383 -
An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
|
Phase 2 |
|
Completed
|
NCT01284920 -
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
|
Phase 1/Phase 2 |
|
Completed
|
NCT02319239 -
Prostate Cancer Stereotactic Radiotherapy
|
N/A |
|
Completed
|
NCT00910754 -
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 1 |
|
Completed
|
NCT00972309 -
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
|
Phase 1 |
|
Terminated
|
NCT03531827 -
Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment
|
Phase 2 |
|
Completed
|
NCT00167648 -
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer
|
Phase 2 |
|
Not yet recruiting
|
NCT05577689 -
Novel Therapy Target in Metastatic Prostate Cancer
|
|
|
Enrolling by invitation
|
NCT03173924 -
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
|
Phase 2 |
|
Completed
|
NCT01477749 -
Sipuleucel-T Manufacturing Demonstration Study
|
Phase 2 |